Skip to main content

Engineering of Mycoplasma pneumoniae as a broad-spectrum animal vaccine

Ziel

Mycoplasmas are the smallest cell wall less, free-living microorganisms. The lack of a cell wall makes them resistant to many of the common antibiotics. Every year, infections caused by Mycoplasmas in poultry, cows, and pigs, result in multimillion euros losses in USA and Europe. Currently, there are vaccines against M hyopneumoniae in pigs and M gallisepticum and M synoviae in poultry. However, there is no vaccination against many Mycoplasma species infecting pets, humans and farm animals (ie M bovis cow infection). Mycoplasma species in many cases are difficult to grown in axenic culture and those that grow need a complex media with animal serum. In large scale production of Mycoplasma species for vaccination aside from the high cost of animal serum, more important is the high irreproducibility in the production process and the possible contamination with animal viruses. All this together highlights what European industry needs:i) a defined cheap reproducible medium that is animal serum free and ii) an universal Mycoplasma chassis that could be used in a pipeline to vaccinate against Mycoplasma species, as well as any pathogen. M pneumoniae is an ideal starting point for designing such a vaccine chassis. It has a small genome (860 kb) and it is probably the organism with the most comprehensive systems biology data acquired so far. By genome comparison, metabolic modeling and rationally engineering its genome, we will create a vaccine chassis that will be introduced into an industrial pipeline. The process will be guided by the second world largest industry on animal vaccination (MSD), as well as a SME specialized on peptide display and screening. This will ensure the exploitation and commercialization of our work contributing to maintain Europe privileged position in this field. Our ultimate goal is to meet the needs of the livestock industry,taking care of ethical issues, foreseeable risks, and prepare effective dissemination and training material for the public.

Wissenschaftliches Gebiet

  • /Naturwissenschaften/Biowissenschaften/Genetik und Vererbung/Genom
  • /Agrarwissenschaften/Tier- und Molkereiwissenschaft/Haustiere
  • /Naturwissenschaften/Biowissenschaften/Mikrobiologie/Virologie
  • /Naturwissenschaften/Biowissenschaften/synthetische Biologie
  • /Sozialwissenschaften/Wirtschaftswissenschaften/Wirtschaftswissenschaft/Produktionswirtschaft
  • /Medizin- und Gesundheitswissenschaften/Grundlagenmedizin/Pharmakologie und Pharmazie/Arzneimittelresistenz/Antibiotikaresistenzen

Aufforderung zur Vorschlagseinreichung

H2020-LEIT-BIO-2014-1
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

RIA - Research and Innovation action

Koordinator

FUNDACIO CENTRE DE REGULACIO GENOMICA
Adresse
Carrer Doctor Aiguader 88
08003 Barcelona
Spanien
Aktivitätstyp
Research Organisations
EU-Beitrag
€ 2 128 507

Beteiligte (7)

INTERVET INTERNATIONAL BV
Niederlande
EU-Beitrag
€ 1 476 250
Adresse
Wim De Korverstraat 35
5831 AN Boxmeer
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Frankreich
EU-Beitrag
€ 850 300
Adresse
147 Rue De L'universite
75007 Paris Cedex 07
Aktivitätstyp
Research Organisations
WAGENINGEN UNIVERSITY
Niederlande
EU-Beitrag
€ 860 008
Adresse
Droevendaalsesteeg 4
6708 PB Wageningen
Aktivitätstyp
Higher or Secondary Education Establishments
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom
EU-Beitrag
€ 699 977
Adresse
South Kensington Campus Exhibition Road
SW7 2AZ London
Aktivitätstyp
Higher or Secondary Education Establishments
ATG:BIOSYNTHETICS GMBH
Deutschland
EU-Beitrag
€ 897 493
Adresse
Weberstrasse 40
79249 Merzhausen
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
KOBENHAVNS UNIVERSITET
Dänemark
EU-Beitrag
€ 591 750
Adresse
Norregade 10
1165 Kobenhavn
Aktivitätstyp
Higher or Secondary Education Establishments
BIOFACTION KG
Österreich
EU-Beitrag
€ 552 392
Adresse
Kundmanngasse 39/12
1030 Wien
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)